BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31686905)

  • 1. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Cui W; Chen R; Guo K; Zhang H; Chen S; Wang Z
    Cancer Manag Res; 2019; 11():7857-7866. PubMed ID: 31686905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis.
    Ren S; Qian L; Daniels MJ; Duan S; Chen R; Wang Z
    Eur J Radiol; 2020 Dec; 133():109360. PubMed ID: 33126171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
    Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
    Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Texture Analysis for the Differential Diagnosis of Mass-Forming Pancreatitis From Pancreatic Ductal Adenocarcinoma on Contrast-Enhanced CT Images.
    Ren S; Zhang J; Chen J; Cui W; Zhao R; Qiu W; Duan S; Chen R; Chen X; Wang Z
    Front Oncol; 2019; 9():1171. PubMed ID: 31750254
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis.
    Ye Y; Zhang J; Song P; Qin P; Hu Y; An P; Li X; Lin Y; Wang J; Feng G
    Technol Cancer Res Treat; 2023; 22():15330338231180792. PubMed ID: 37287274
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
    Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
    Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
    Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
    PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis.
    Guo C; Zhuge X; Wang Q; Xiao W; Wang Z; Wang Z; Feng Z; Chen X
    Cancer Imaging; 2018 Oct; 18(1):37. PubMed ID: 30333055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
    Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
    Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.
    Kim M; Jang KM; Kim JH; Jeong WK; Kim SH; Kang TW; Kim YK; Cha DI; Kim K
    Eur Radiol; 2017 Apr; 27(4):1722-1732. PubMed ID: 27510628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of enhanced CT features and texture-signatures in assessing the inflammatory infiltration of pancreatic ductal adenocarcinoma.
    Wang F; Guo H; Li S; Xu J; Yu D
    Front Oncol; 2023; 13():1078861. PubMed ID: 36816950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT Abnormalities of the Pancreas Associated With the Subsequent Diagnosis of Clinical Stage I Pancreatic Ductal Adenocarcinoma More Than 1 Year Later: A Case-Control Study.
    Toshima F; Watanabe R; Inoue D; Yoneda N; Yamamoto T; Sasahira N; Sasaki T; Matsuyama M; Minehiro K; Tateishi U; Gabata T
    AJR Am J Roentgenol; 2021 Dec; 217(6):1353-1364. PubMed ID: 34161128
    [No Abstract]   [Full Text] [Related]  

  • 16. Diffuse pancreatic parenchymal atrophy, an imaging finding predictive of the development of pancreatic ductal adenocarcinoma: A case-control study.
    Koiwai A; Hirota M; Matsuura T; Itoh T; Kin R; Katayama T; Endo K; Takasu A; Kogure T; Murakami K; Satoh K
    JGH Open; 2023 Jun; 7(6):445-452. PubMed ID: 37359111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma with CT radiomics features.
    Park S; Chu LC; Hruban RH; Vogelstein B; Kinzler KW; Yuille AL; Fouladi DF; Shayesteh S; Ghandili S; Wolfgang CL; Burkhart R; He J; Fishman EK; Kawamoto S
    Diagn Interv Imaging; 2020 Sep; 101(9):555-564. PubMed ID: 32278586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated Main Pancreatic Duct Dilatation: CT Differentiation Between Benign and Malignant Causes.
    Kim SW; Kim SH; Lee DH; Lee SM; Kim YS; Jang JY; Han JK
    AJR Am J Roentgenol; 2017 Nov; 209(5):1046-1055. PubMed ID: 28858540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
    Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
    Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatitis and PDAC: association and differentiation.
    Elsherif SB; Virarkar M; Javadi S; Ibarra-Rovira JJ; Tamm EP; Bhosale PR
    Abdom Radiol (NY); 2020 May; 45(5):1324-1337. PubMed ID: 31705251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.